(Q36988902)

17 August 2017

Possible adverse effects of SGLT2 inhibitors on bone (English)

1 reference

17 August 2017

Simeon I Taylor

1

1 reference

PMCID

4900761

17 August 2017

Jenny E Blau

series ordinal

2

1 reference

PMCID

4900761

17 August 2017

Kristina I Rother

series ordinal

3

1 reference

17 August 2017

16 December 2014

1 reference

The Lancet: Diabetes & Endocrinology

17 August 2017

1 reference

17 August 2017

3

1 reference

17 August 2017

1

1 reference

17 August 2017

8-10

1 reference

SGLT inhibitors in management of diabetes

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Bone as a source of FGF23: regulation by phosphate?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

The role of phosphate in the secretion of parathyroid hormone in man

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Dapagliflozin, a novel SGLT2 inhibitor, induces dose-dependent glucosuria in healthy subjects

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4900761

Effect of phloridzin on uric acid excretion in man

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970227-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970227-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S2213-8587(14)70227-X

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

PMCID

4900761